Rehmann Capital Advisory Group’s Rockwell Medical RMTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-559
| Closed | -$29K | – | 545 |
|
|
2022
Q1 | $29K | Hold |
559
| – | – | ﹤0.01% | 534 |
|
|
2021
Q4 | $25.2K | Hold |
559
| – | – | ﹤0.01% | 561 |
|
|
2021
Q3 | $36.7K | Hold |
559
| – | – | ﹤0.01% | 542 |
|
|
2021
Q2 | $56K | Hold |
559
| – | – | 0.01% | 541 |
|
|
2021
Q1 | $71.4K | Hold |
559
| – | – | 0.01% | 510 |
|
|
2020
Q4 | $62.1K | Sell |
559
-102
| -15% | -$11.4K | 0.01% | 480 |
|
|
2020
Q3 | $77.8K | Hold |
661
| – | – | 0.01% | 422 |
|
|
2020
Q2 | $142K | Hold |
661
| – | – | 0.02% | 407 |
|
|
2020
Q1 | $149K | Buy |
+661
| New | +$188K | 0.02% | 366 |
|
|
2019
Q3 | $201K | Hold |
661
| – | – | 0.02% | 312 |
|
|
2019
Q2 | $219K | Hold |
661
| – | – | 0.03% | 414 |
|
|
2019
Q1 | $414K | Hold |
661
| – | – | 0.06% | 256 |
|
|
2018
Q4 | $164K | Buy |
661
+114
| +21% | +$45.4K | 0.02% | 286 |
|
|
2018
Q3 | $254K | Buy |
547
+118
| +28% | +$57.2K | 0.04% | 343 |
|
|
2018
Q2 | $233K | Buy |
429
+102
| +31% | +$61.2K | 0.03% | 335 |
|
|
2018
Q1 | $187K | Buy |
327
+18
| +6% | +$11.4K | 0.03% | 391 |
|
|
2017
Q4 | $198K | Hold |
309
| – | – | 0.03% | 373 |
|
|
2017
Q3 | $291K | Hold |
309
| – | – | 0.05% | 270 |
|
|
2017
Q2 | $269K | Hold |
309
| – | – | 0.05% | 282 |
|
|
2017
Q1 | $213K | Hold |
309
| – | – | 0.04% | 360 |
|
|
2016
Q4 | $223K | Buy |
309
+18
| +6% | +$12.4K | 0.04% | 344 |
|
|
2016
Q3 | $214K | Buy |
291
+74
| +34% | +$59.9K | 0.04% | 336 |
|
|
2016
Q2 | $180K | Buy |
217
+60
| +38% | +$55.8K | 0.03% | 351 |
|
|
2016
Q1 | $130K | Buy |
157
+5
| +3% | +$3.93K | 0.03% | 351 |
|
|
2015
Q4 | $171K | Hold |
152
| – | – | 0.04% | 330 |
|
|
2015
Q3 | $129K | Hold |
152
| – | – | 0.03% | 319 |
|
|
2015
Q2 | $269K | Hold |
152
| – | – | 0.06% | 251 |
|
|
2015
Q1 | $182K | Buy |
152
+39
| +35% | +$45.7K | 0.04% | 330 |
|
|
2014
Q4 | $128K | Buy |
113
+12
| +12% | +$12.3K | 0.03% | 323 |
|
|
2014
Q3 | $101K | Buy |
101
+1
| +1% | +$1.13K | 0.02% | 331 |
|
|
2014
Q2 | $132K | Buy |
100
+9
| +10% | +$10.8K | 0.03% | 316 |
|
|
2014
Q1 | $127K | Hold |
91
| – | – | 0.03% | 312 |
|
|
2013
Q4 | $104K | Hold |
91
| – | – | 0.03% | 300 |
|
|
2013
Q3 | $114K | Hold |
91
| – | – | 0.04% | 273 |
|
|
2013
Q2 | $36K | Buy |
+91
| New | +$38.6K | 0.01% | 262 |
|
Other funds holding RMTI
RB
PCM
VCA
SW
Rehmann Capital Advisory Group's RMTI Position: Q2 2022 in Review
Rehmann Capital Advisory Group sold out of Rockwell Medical (RMTI) in Q2 2022, closing a stake of 559 shares — an estimated $29K sold.
Rehmann Capital Advisory Group first reported a position in RMTI in Q2 2013 and held it in 35 quarters. The position peaked at $414K in Q1 2019. 36 funds tracked by Wall St. Rank hold RMTI as of Q2 2022.
- Rehmann Capital Advisory Group reported no remaining Rockwell Medical position as of Q2 2022 after selling out during the quarter.
- Rehmann Capital Advisory Group sold 559 Rockwell Medical shares in Q2 2022, an estimated $29K.
- Rehmann Capital Advisory Group first reported a position in Rockwell Medical in Q2 2013 and held it in 35 quarters.
- Rehmann Capital Advisory Group's Rockwell Medical position peaked at $414K in Q1 2019.
- 36 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2022.
Based on Rehmann Capital Advisory Group's 13F filing for Q2 2022, filed 12 Aug 2022.